Ark Sells Huya, Novartis Shares; Buys UiPath, Recursion Pharma
Exchange-traded funds managed by Cathie Wood’s ArkInvestment Management sold about 273,735 American depository receipts of Huya Inc.
Ark funds also sold 71,238 Novartis AG ADRs, while they bought 247,130 UiPath Inc. shares, 65,737 Recursion Pharmaceuticals Inc. and 58,914 Signify Health Inc. shares.
Ark funds also sold 71,238 Novartis AG ADRs, while they bought 247,130 UiPath Inc. shares, 65,737 Recursion Pharmaceuticals Inc. and 58,914 Signify Health Inc. shares.
China’s antitrust regulators on Saturday rejected Huya’s proposal to merge with DouYu International Holdings Ltd, saying that it would give Tencent Holdings Ltd.-- which owns stakes in both companies -- an unfair advantage in the country’s game streaming market.
$HUYA Inc(HUYA.US$
$TENCENT(00700.HK$
$Novartis AG(NVS.US$
$UiPath(PATH.US$
$Recursion Pharmaceuticals(RXRX.US$
$Signify Health, Inc.(SGFY.US$
$HUYA Inc(HUYA.US$
$TENCENT(00700.HK$
$Novartis AG(NVS.US$
$UiPath(PATH.US$
$Recursion Pharmaceuticals(RXRX.US$
$Signify Health, Inc.(SGFY.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Twitter@Sino_Market | Realtime Chinese market info provider.
9229Followers
4Following
8777Visitors
Follow